|
|
Volumn 24, Issue 8, 1999, Pages 647-651
|
|
Transcoronary ablation of septal hypertrophy (TASH): supersedes it the surgery (myectomy)?;Transkoronare Ablation der Septumhypertrophie (TASH): Ersetzt sie die Operation (Myektomie)?
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIARRHYTHMIC AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
PROPRANOLOL;
VASODILATOR AGENT;
VERAPAMIL;
ARTICLE;
ARTIFICIAL HEART PACEMAKER;
CATHETER ABLATION;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CROSSOVER PROCEDURE;
HEART ARRHYTHMIA;
HEART VENTRICLE SEPTUM;
HUMAN;
HYPERTROPHIC CARDIOMYOPATHY;
POSTOPERATIVE COMPLICATION;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIAL;
TRANSESOPHAGEAL ECHOCARDIOGRAPHY;
ANTI-ARRHYTHMIA AGENTS;
ARRHYTHMIA;
CALCIUM CHANNEL BLOCKERS;
CARDIOMYOPATHY, HYPERTROPHIC;
CATHETER ABLATION;
CROSS-OVER STUDIES;
ECHOCARDIOGRAPHY, TRANSESOPHAGEAL;
HEART SEPTUM;
HUMANS;
PACEMAKER, ARTIFICIAL;
POSTOPERATIVE COMPLICATIONS;
PROGNOSIS;
PROPRANOLOL;
RANDOMIZED CONTROLLED TRIALS;
VASODILATOR AGENTS;
VERAPAMIL;
|
|
EID: 0033249755
PISSN: 03409937
EISSN: None
Source Type: Journal
DOI: 10.1007/BF03044490 Document Type: Article |
|
Times cited : (7)
|
|
References (0)
|
